White matter abnormality in Jacobsen syndrome assessed by serial MRI.

Cerebral white matter abnormality Hepatic and glial cell adhesion molecules (HEPACAM/GlialCAM) Jacobsen syndrome Megalencephalic leukoencephalopathy with subcortical cysts type 2B (MLC2B)

Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 12 02 2020
revised: 09 04 2020
accepted: 03 05 2020
pubmed: 9 6 2020
medline: 5 5 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Jacobsen syndrome (JS) is caused by a deletion at the terminus of the long arm of chromosome 11. There are few reports of JS associated with cerebral white matter abnormalities (WMA), and the etiology, pathophysiology, and time-dependent changes in WMA with JS still remain unclear. The patient was a 2-month-old female with several morphological anomalies, including trigonocephaly, ectropion, flat nasal bridge, low-set ears, and sparse eyebrows. Chromosome analysis (G-banding karyotyping) of 46,XX,del(11)(q23.3) led to the diagnosis of JS. Head MRI performed at age 9 months indicated diffuse WMA with hyperintense signals on T2-weighted imaging. MRI at age 2.5 years demonstrated a decrease in the WMA and progressive myelination. These findings suggested that the WMA in the present patient were due to chronic white matter edema associated with a deletion in the 11q terminal region of HEPACAM/GlialCAM, a causative gene for megalencephalic leukoencephalopathy with subcortical cysts type 2B (MLC2B). As with some of MLC2B patients, the WMA in the present patient improved over time. The present report is the first to document dramatic changes in WMA in JS visualized by serial MRI examinations from the neonatal period through early childhood. The findings of the present study suggested that WMA in JS are due to chronic white matter edema associated with HEPACAM/GlialCAM deletion and show gradual improvement over time, as seen in some MLC2B patients.

Identifiants

pubmed: 32507665
pii: S0387-7604(20)30140-6
doi: 10.1016/j.braindev.2020.05.001
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-625

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Auteurs

Shuhei Fujino (S)

Department of Neurology, Tokyo Metropolitan Children's Medical Center, Japan. Electronic address: n_r_h_c_1616@yahoo.co.jp.

Hiroshi Yoshihashi (H)

Department of Medical Genetics, Tokyo Metropolitan Children's Medical Center, Japan.

Ryojun Takeda (R)

Department of Medical Genetics, Tokyo Metropolitan Children's Medical Center, Japan.

Satoshi Ihara (S)

Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center, Japan.

Sahoko Miyama (S)

Department of Neurology, Tokyo Metropolitan Children's Medical Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH